This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

Evox Therapeutics expands its exosome manufacturing patent portfolio

Evox Therapeutics expands its exosome manufacturing patent portfolio

07 Sep 2022

EVOX THERAPEUTICS EXPANDS ITS EXOSOME MANUFACTURING PATENT PORTFOLIO Four newly issued patents cover key purification processes and methods of exogenous loading OXFORD, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad range of exosome manufacturing methods and... Read more

Milestone reached in next phase of TOSP development following successful public consultation

Milestone reached in next phase of TOSP development following successful public consultation

06 Sep 2022

Milestone reached in next phase of TOSP development  following successful public consultation Detailed new planning applications submitted for three new buildings  on Plots 23-26 Oxford, UK, September 6 2022 – Significant progress has been made in the expansion of The Oxford Science Park (TOSP), one of Europe's leading locations for science and technology companies, with the submission of detailed planning applications for three new... Read more

Gilead Sciences to Acquire MiroBio

Gilead Sciences to Acquire MiroBio

04 Aug 2022

Acquisition Provides Gilead with MiroBio’s Pipeline of Immune Checkpoint Agonists and Proprietary Discovery Platform MiroBio’s Scientific Approach to Restoring Immune Balance for the Treatment of Autoimmune Diseases Complements Gilead’s Inflammation Research and Development Strategy Foster City, Calif. and Oxford, U.K., August 4, 2022 – Gilead Sciences, Inc. (Nasdaq: GILD) and MiroBio, a privately-held U.K.-based biotechnology company... Read more

Digital Catapult unveils five firms to explore potential of Open RAN technology on SONIC Labs testbed

Digital Catapult unveils five firms to explore potential of Open RAN technology on SONIC Labs testbed

18 Jul 2022

Digital Catapult, with support from its partner Ofcom, has onboarded five companies to its SONIC Labs programme to trial the integration of Open RAN (Radio Access Network) products into working end-to-end systems Participating organisations will work collaboratively with each other, Digital Catapult and Ofcom to integrate and test their products in lab and indoor mobile network settings, accelerating their route to... Read more

Oxford Science Enterprises Raises £250 Million

Oxford Science Enterprises Raises £250 Million

18 Jul 2022

New funding deepens capital pool available to drive the creation and growth of transformational businesses built on ground-breaking Oxford science Oxford, UK: July 18, 2022 – Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, today announces it has raised a further £250 million ($300... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More